Contribution of degradation products to the anticancer activity of curcumin.
Shen
Liang
L
Ji
Hong-Fang
HF
D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001682:Biological Availability; D003474:Curcumin / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D016328:NF-kappa B / Q000378:metabolism; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D013696:Temperature
D000970:Antineoplastic Agents; D016328:NF-kappa B; D003474:Curcumin